| Literature DB >> 35810102 |
A M Mudarra Vela1, F Rivas Ruiz2, J Atienza Carrasco3, F J Medina Cano2.
Abstract
INTRODUCTION AND AIMS: Gastrointestinal perforation is a surgical emergency that is associated with a high mortality rate and requires special care. During the pandemic, there has been competition with COVID-19 patients for health resources, especially ICU bed availability. The primary aim of our study was to compare the incidence of gastrointestinal perforation during the COVID-19 pandemic, with cases registered before the pandemic.Entities:
Keywords: COVID-19; Cirugía urgente; Emergency surgery; Gastrointestinal perforation; Pandemia; Pandemic; Perforación gastrointestinal
Year: 2022 PMID: 35810102 PMCID: PMC9192794 DOI: 10.1016/j.rgmxen.2022.06.008
Source DB: PubMed Journal: Rev Gastroenterol Mex (Engl Ed) ISSN: 2255-534X
Accumulated incidence and mortality rates of perforations.
| Variable | Before the pandemic | During the pandemic | Rate ratios |
|---|---|---|---|
| (95% CI) | |||
| Time evaluated (months) | 12 | 6 | |
| Number of perforations | 33 | 34 | |
| Number of emergency interventions | 661 | 345 | |
| Number of in-hospital fatal outcomes | 5 | 10 | |
| Perforation rate per intervention (%) | 4.99 | 9.86 | 1.97(1.30-2.99) |
| Fatal outcome rate per intervention (%) | 0.76 | 2.9 | 3.83 (1.44-10.2) |
| Fatal outcome rate per perforation (%) | 15.2 | 29.4 | 1.94 (0.73-5.17) |
Sociodemographic and clinical characteristics regarding perforations in the two study periods.
| Variable | Before the pandemic | During the pandemic | p |
|---|---|---|---|
| (12 months) n = 33 | (6 months) n = 34 | ||
| Sex (female), n (%) | 12 (36.4) | 10 (29.4) | 0.730 |
| Age, mean (SD) | 61.3 (14.9) | 62.2 (16.3) | 0.820 |
| Nationality (foreigner), n (%) | 11 (33.3) | 15 (44.1) | 0.513 |
| Resident of the area (Yes), n (%) | 30 (90.9) | 25 (73.5) | 0.124 |
| Charlson comorbidity index, median (IQR) | 2 (3) | 1.5 (4.25) | 0.320 |
| Care time (hours), median (IQR) | 14 (99) | 18.5 (208) | 0.589 |
| ICU admission (Yes), n (%) | 19 (57.6) | 13 (38.2) | 0.180 |
| ICU stay (hours), median (IQR) | 24 (152) | 161 (172) | 0.009 |
| Hospital stay duration (days), median (IQR) | 11 (18) | 16 (13.5) | 0.318 |
ICU: intensive care unit; IQR: interquartile range; SD: standard deviation.
Figure 1Perforation site distribution. Results are expressed as the number of cases per period. Each column corresponds to a location and each column segment to the cases in each period at that location.
Figure 2Perforation cause distribution. Results are expressed as the percentage of cases per period. Each column corresponds to a cause and each segment indicates the percentage of cases in each period. The total number of perforations (n) for each cause is indicated below each column.
Distribution of surgical risk results; frequency and percentage.
| Scale | (Value) | Before the pandemic | During the pandemic | p |
|---|---|---|---|---|
| (12 months) n = 33 | (6 months) n = 34 | |||
| CEPOD | 3 | 5 (15.2) | 7 (20.6) | 0.794 |
| 4 | 28 (84.8) | 27 (79.4) | ||
| BUPA | 3 | 8 (24.2) | 16 (47.1) | 0.019 |
| 4 | 22 (66.7) | 18 (52.9) | ||
| 5 | 3 (9.1) | 0 (0) | ||
| ASA | 1 | 5 (15.2) | 4 (11.8) | 0.175 |
| 2 | 13 (39.4) | 11 (32.4) | ||
| 3 | 12 (36.4) | 10 (29.4) | ||
| 4 | 3 (9.1) | 9 (26.5) |
Confidential Enquiry into Perioperative Deaths.
British United Provident Association.
American Society of Anesthesiologists.
Figure 3Profile, past medical history, and progression of COVID-19-positive patients with gastrointestinal perforation in the study period (01/09/2020 to 28/02/2021).
AIDS: acquired immunodeficiency syndrome; COPD: chronic obstructive pulmonary disease; LTE: limitation of the therapeutic effort.